Episode 211: Unlocking Mescaline's Healing Powers: Lophos Holdings $MESC Takes the Lead

Lophos Holdings Inc. (CSE: MESC) is about to be the first company to make regular sales of psychedelic products in Canada and has been granted a Controlled Drugs and Substances Dealer's License, shares President and CEO Claire Stawnyczy. Discover the amazing journey of Lophos, a bioscience company that focuses on the research of mescaline, a compound of the peyote cactus or Lophophora williamsii. For more information, visit: https://lophos.com/ Watch the full YouTube interview here: https://www.youtube.com/watch?v=pQyrI5yCWHE And follow us to stay updated: https://www.youtube.com/@GlobalOneMedia?sub_confirmation=1